SCHEMBL18355808

SCHEMBL18355808

CC(C)(C)Cc1ccc(F)c(CO)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.44
CYP4F2 P78329 1/20 0.37
CYP4A11 Q02928 1/20 0.37
MAPK1 P28482 1/20 0.35
MAP2K4 P45985 1/20 0.35
MAPKAPK2 P49137 1/20 0.35
MAPKAPK3 Q16644 1/20 0.35
MAPK6 Q16659 1/20 0.35
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
KLF10 Q13118 1/20 0.34
KIF11 P52732 1/20 0.34
GCGR P47871 1/20 0.34
SOAT1 P35610 1/20 0.33
HPGD P15428 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
RIPK1 Q13546 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16116515 0.85 ESR1 (0.44) ESR1CYP4F2CYP4A11THRATHRB
SCHEMBL25751730 0.82 ESR1 (0.48) ESR1THRATHRBKLF10HPGD
SCHEMBL2867572 0.81 ESR1 (0.39) ESR1THRATHRBSOAT1MAOB
SCHEMBL24226063 0.81 ESR1 (0.47) ESR1THRATHRBKLF10HPGD
SCHEMBL28182676 0.80 CYP4F2 (0.47) CYP4F2CYP4A11MAPK1MAP2K4MAPKAPK2
SCHEMBL18361611 0.79 CNR1 (0.46) CYP4F2CYP4A11MAPK1MAP2K4MAPKAPK2
SCHEMBL8773286 0.79 TRPA1 (0.43) CYP4F2CYP4A11MAPK1MAP2K4MAPKAPK2
SCHEMBL73649 0.78 ESR1 (0.46) ESR1THRATHRBSOAT1MAOA
SCHEMBL17013416 0.76 ESR1 (0.45) ESR1THRATHRBKLF10HPGD
SCHEMBL10289724 0.76 ESR1 (0.36) ESR1MAPK1KIF11RIPK1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170001990-A1 PIPERIDINE-DIONE DERIVATIVES GENENTECH, INC. (US) 2017-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170001990-A1 PIPERIDINE-DIONE DERIVATIVES DRD4, ADORA1, ADORA3 ESR1 512/4885CYP4F2 1505/4885CYP4A11 997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.